• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α1-抗糜蛋白酶和α1-蛋白酶抑制剂对组织蛋白酶G抑制作用的动力学机制

Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.

作者信息

Duranton J, Adam C, Bieth J G

机构信息

Laboratoire d'Enzymologie, INSERM U 392, Université Louis Pasteur de Strasbourg, France.

出版信息

Biochemistry. 1998 Aug 11;37(32):11239-45. doi: 10.1021/bi980223q.

DOI:10.1021/bi980223q
PMID:9698370
Abstract

Uncontrolled proteolysis due to cathepsin G (cat G) may cause severe pathological disorders. Cat G is inhibited by alpha 1-antichymotrypsin (ACT) and alpha 1-proteinase inhibitor (alpha 1PI), two members of the serpin superfamily of proteins. To see whether these two inhibitors play a physiological proteolysis-preventing function, we have made a detailed kinetic investigation of their reaction with cat G. The kinetics of inhibition of cat G in the presence of inhibitor and substrate evidenced a two-step inhibition mechanism: E + I EI EI. The cat G/ACT interaction is described by Ki = 6.2 x 10(-)8 M and k2 = 2.8 x 10(-)2 s-1, while the cat G/alpha 1PI association is governed by Ki = 8.1 x 10(-)7 M and k2 = 5.5 x 10(-)2 s-1. The reliability of these kinetic constants was checked using a number of experiments which all gave consistent results: (i) both EI complexes were found to be enzymatically inactive, (ii) the Ki values were determined directly using initial velocity experiments of cat G-catalyzed hydrolysis of substrate in the presence of inhibitor, (iii) the second-order rate constants k2/Ki were measured using second-order inhibition experiments in the absence of substrate, and (iv) the ratio of the two second-order rate constants was determined by measuring the partition of cat G between the two fluorescently labeled serpins. Since the plasma concentrations of ACT and alpha 1PI are much higher than their Ki values, cat G released from neutrophils will be fully taken up as rapidly forming EI complexes, that is, 70% with ACT and 30% with alpha 1PI. Both ACT and alpha 1PI are thus physiological cat G inhibitors whose inhibitory potential does not depend on the formation of the stable inhibitory species EI characteristic of serpins. Such an in vivo inhibition mechanism might take place with other serpin/proteinase systems.

摘要

组织蛋白酶G(cat G)导致的不受控制的蛋白水解可能会引发严重的病理紊乱。Cat G受到α1 - 抗糜蛋白酶(ACT)和α1 - 蛋白酶抑制剂(α1PI)的抑制,这两种蛋白是丝氨酸蛋白酶抑制剂(serpin)超家族的成员。为了探究这两种抑制剂是否发挥生理上防止蛋白水解的功能,我们对它们与cat G的反应进行了详细的动力学研究。在存在抑制剂和底物的情况下对cat G抑制的动力学证明了一种两步抑制机制:E + I→EI→EI。cat G与ACT相互作用的描述为Ki = 6.2×10⁻⁸ M,k2 = 2.8×10⁻² s⁻¹,而cat G与α1PI的结合由Ki = 8.1×10⁻⁷ M和k2 = 5.5×10⁻² s⁻¹决定。通过一系列实验检验了这些动力学常数的可靠性,所有实验结果均一致:(i)发现两种EI复合物均无酶活性;(ii)Ki值通过在存在抑制剂的情况下cat G催化底物水解的初始速度实验直接测定;(iii)二级速率常数k2/Ki通过在不存在底物的情况下的二级抑制实验测量;(iv)通过测量cat G在两种荧光标记的丝氨酸蛋白酶抑制剂之间的分配来确定两个二级速率常数的比值。由于ACT和α1PI的血浆浓度远高于它们的Ki值,从中性粒细胞释放的cat G将迅速形成EI复合物而被完全摄取,即70%与ACT结合,30%与α1PI结合。因此,ACT和α1PI都是生理性的cat G抑制剂,其抑制潜力不依赖于丝氨酸蛋白酶抑制剂特有的稳定抑制物种EI的形成。这种体内抑制机制可能也适用于其他丝氨酸蛋白酶抑制剂/蛋白酶系统。

相似文献

1
Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.α1-抗糜蛋白酶和α1-蛋白酶抑制剂对组织蛋白酶G抑制作用的动力学机制
Biochemistry. 1998 Aug 11;37(32):11239-45. doi: 10.1021/bi980223q.
2
Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.肝素可保护组织蛋白酶G不被蛋白酶抑制剂抑制。
J Biol Chem. 1994 Nov 25;269(47):29502-8.
3
Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.氧化黏液蛋白酶抑制剂对中性粒细胞组织蛋白酶G的抑制作用。肝素的影响。
Biochemistry. 1999 Jun 29;38(26):8451-7. doi: 10.1021/bi9828526.
4
Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.肿瘤坏死因子-α通过中性粒细胞释放的组织蛋白酶G增强血小板活化。
J Immunol. 1991 Apr 1;146(7):2305-9.
5
DNA strongly impairs the inhibition of cathepsin G by alpha(1)-antichymotrypsin and alpha(1)-proteinase inhibitor.
J Biol Chem. 2000 Feb 11;275(6):3787-92. doi: 10.1074/jbc.275.6.3787.
6
Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo.α1-抗胰蛋白酶在体外对蛋白酶3的抑制作用预示着其在体内的抑制作用非常迅速。
Am J Respir Cell Mol Biol. 2003 Jul;29(1):57-61. doi: 10.1165/rcmb.2002-0258OC. Epub 2003 Jan 15.
7
Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.重组水蛭素(一种从水蛭中提取的蛋白酶抑制剂)对中性粒细胞介导的血小板活化的干扰作用。
Lab Invest. 1990 Apr;62(4):409-16.
8
Studies on inhibition of neutrophil cathepsin G by alpha 1-antichymotrypsin.
Inflammation. 1995 Feb;19(1):75-81. doi: 10.1007/BF01534382.
9
Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis.α-1-蛋白酶抑制剂对中性粒细胞趋化性的影响。
Am J Respir Cell Mol Biol. 1990 Feb;2(2):163-70. doi: 10.1165/ajrcmb/2.2.163.
10
Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.炎症相关的中性粒细胞蛋白酶、组织蛋白酶G和弹性蛋白酶,可作为胰岛素样生长因子结合蛋白蛋白酶发挥作用。
Growth Horm IGF Res. 1999 Aug;9(4):241-53. doi: 10.1054/ghir.1999.0115.

引用本文的文献

1
Oxidant-Based Cytotoxic Agents During Aging: From Disturbed Energy Metabolism to Chronic Inflammation and Disease Progression.衰老过程中基于氧化剂的细胞毒性剂:从能量代谢紊乱到慢性炎症和疾病进展
Biomolecules. 2025 Apr 9;15(4):547. doi: 10.3390/biom15040547.
2
Genotypic Frequencies of Mutations Associated with Alpha-1 Antitrypsin Deficiency in Unrelated Bone Marrow Donors from the Murcia Region Donor Registry in the Southeast of Spain.西班牙东南部穆尔西亚地区供体登记处无关骨髓供体中与α-1抗胰蛋白酶缺乏症相关突变的基因型频率
Diagnostics (Basel). 2023 Sep 2;13(17):2845. doi: 10.3390/diagnostics13172845.
3
Host-Derived Cytotoxic Agents in Chronic Inflammation and Disease Progression.
慢性炎症与疾病进展中的宿主源性细胞毒性因子
Int J Mol Sci. 2023 Feb 3;24(3):3016. doi: 10.3390/ijms24033016.
4
Engineering the serpin α -antitrypsin: A diversity of goals and techniques.工程化丝氨酸蛋白酶抑制剂 α1-抗胰蛋白酶:多样化的目标和技术。
Protein Sci. 2020 Apr;29(4):856-871. doi: 10.1002/pro.3794. Epub 2019 Dec 9.
5
Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics.在糖尿病前期患者和未经治疗的 2 型糖尿病患者中存在明显不同的肠道宏基因组和宏蛋白质组特征。
EBioMedicine. 2019 Sep;47:373-383. doi: 10.1016/j.ebiom.2019.08.048. Epub 2019 Sep 3.
6
Evidence for a Role of Nerve Injury in Painful Intervertebral Disc Degeneration: A Cross-Sectional Proteomic Analysis of Human Cerebrospinal Fluid.神经损伤在椎间盘疼痛性退变中的作用证据:人脑脊液的跨组学分析。
J Pain. 2017 Oct;18(10):1253-1269. doi: 10.1016/j.jpain.2017.06.002. Epub 2017 Jun 24.
7
iTRAQ-Based Proteomics Analysis of Serum Proteins in Wistar Rats Treated with Sodium Fluoride: Insight into the Potential Mechanism and Candidate Biomarkers of Fluorosis.基于iTRAQ的氟化钠处理Wistar大鼠血清蛋白质组学分析:深入了解氟中毒的潜在机制和候选生物标志物
Int J Mol Sci. 2016 Sep 28;17(10):1644. doi: 10.3390/ijms17101644.
8
Association between alpha-1 antichymotrypsin gene A/T polymorphism and primary intracerebral hemorrhage: a meta-analysis.α-1抗糜蛋白酶基因A/T多态性与原发性脑出血的关联:一项荟萃分析
Int J Clin Exp Med. 2015 Nov 15;8(11):20796-804. eCollection 2015.
9
Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency.在α1-抗胰蛋白酶缺乏的秀丽隐杆线虫模型中,SERPINA1的缺陷型和无效型变体具有蛋白毒性。
PLoS One. 2015 Oct 29;10(10):e0141542. doi: 10.1371/journal.pone.0141542. eCollection 2015.
10
Is Alpha-1 Antichymotrypsin Gene Polymorphism a Risk Factor for Primary Intracerebral Hemorrhage? A Case-Control Study and Meta-Analysis.α-1抗糜蛋白酶基因多态性是原发性脑出血的危险因素吗?一项病例对照研究和荟萃分析。
Med Sci Monit. 2015 Jul 24;21:2149-55. doi: 10.12659/MSM.894365.